Grantham, Mayo, Van Otterloo & Co (GMO)’s Universal Health Services UHS Stock Holding History
Bought
Maintained
Sold
Other funds holding UHS
Grantham, Mayo, Van Otterloo & Co (GMO)'s UHS Position: Q3 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Universal Health Services (UHS) stake by 20% in Q3 2026, buying an estimated $416K and bringing the position to 14,814 shares worth $2.58M. The position accounts for 0.01% of the portfolio, ranked #421.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in UHS in Q3 2013 and has held it in 28 quarters since. The position peaked at $39.4M in Q4 2022. 638 funds tracked by Wall St. Rank hold UHS as of Q3 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 14,814 shares of Universal Health Services worth $2.58M as of Q3 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 2,480 Universal Health Services shares in Q3 2026, an estimated $416K.
- Universal Health Services made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #421 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Universal Health Services in Q3 2013 and has held it in 28 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Universal Health Services position peaked at $39.4M in Q4 2022.
- 638 funds tracked by Wall St. Rank held Universal Health Services as of Q3 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.